These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-002295-41 A randomised phase II/III study of Docetaxel plus Prednisolone vs. Docetaxel plus Prednisolone plus Zoledronic acid vs. Docetaxel plus Prednisolone plus Strontium-89 vs. Docetaxel plus Prednisolone ... not-yet-due
Listed as ongoing, but also has a completion date 2004-003868-30 BTOG2: A British Thoracic Oncology Group phase III trial of gemcitabine plus cisplatin at 80 mg/m2 versus gemcitabine plus cisplatin at 50 mg/m2 versus gemcitabine plus carboplatin AUC 6 in stage IIIB... 2011-04-01 bad-data
Not reported 2004-004835-72 A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults 2013-10-23 due-trials
Ongoing 2005-000163-25 Proteomics and Pharmacokinetics of Adriamycin Following Different Techniques for Chemoembolisation of Hepatocellular Carcinoma (PPATCH) Trial not-yet-due
Listed as ongoing, but also has a completion date 2005-000217-35 a protocol for patients with localized rhabdomyosarcoma in pediatric age 2016-12-31 bad-data
Ongoing 2005-000550-75 Phase II Study of the Tolerability and Efficacy of the Histone Deacetylase Inhibitor Sodium Valproate given in Conjunction with 5-azacytidine and ATRA (all trans retinoic acid ) in Patients with Acute... not-yet-due
Ongoing 2005-003021-19 The use of selenium and vitamin E supplementation to prevent recurrence and progression of non-muscle-invasive bladder cancer not-yet-due
Ongoing 2005-004196-37 Taurine and Painful Diabetic Neuropathy not-yet-due
Ongoing 2006-000436-27 Neoadjuvant trial of pre-operative exemestane or letrozole +/-celecoxib in the treatment of ER positive postmenopausal early breast cancer. not-yet-due
Ongoing, reported early 2006-005597-43 Topical Retinoids and Diabetic Neuropathic Ulceration not-yet-due
Not reported 2006-005630-21 The effect of Pregabalin on Pain progressing in Painful Diabetic Neuropathy 2014-05-19 due-trials
Not reported 2007-001768-60 A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide with Radiotherapy in Diffuse Pontine Gliomas 2011-05-06 due-trials
Ongoing 2007-001987-55 A randomised trial assessing whether preoperative chemotherapy improves outcome in high-risk operable colon cancer not-yet-due
Ongoing 2007-002402-21 A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate in reducing ototoxicity in patients receiving cisplatin chemotherapy for standard risk hepatoblastoma not-yet-due
Not reported 2007-005396-34 Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL) 2008-12-19 due-trials
Ongoing 2007-006475-36 Phase ll Study of the Adjunctive Use of Azacitidine in Patients Undergoing Reduced Intensity Allogeneic Transplantation for Acute Myeloid Leukaemia not-yet-due
Ongoing 2007-007262-38 Efficacy of adjuvant mitotane in prolonging recurrence-free survival in patients with adrenocortical carcinoma at low-intermediate risk of recurrence not-yet-due
Ongoing 2008-002288-14 Phase I Dose Escalation Study of Clofarabine and Liposomal Daunorubicin in Childhood and Adolescent AML not-yet-due
Ongoing 2008-006433-28 Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial. not-yet-due
Ongoing 2009-010335-41 A MULTICENTRE, PHASE II, OPEN LABEL, RANDOMISED CONTROLLED TRIAL OF REPEATED AUTOLOGOUS INFUSIONS OF G-CSF MOBILISED CD133+ BONE MARROW STEM CELLS IN PATIENTS WITH CIRRHOSIS not-yet-due
Not reported 2009-012752-24 High or Low Dose Syntocinon (Oxytocin) for delay in labour 2011-08-17 due-trials
Ongoing 2009-016761-29 A 48-WEEK PHASE II, RANDOMISED, DOUBLE BLINDED PLACEBO CONTROLLED, PARALLEL-GROUP, MULTI-CENTRE TRIAL ON LIRAGLUTIDE’S SAFETY, EFFICACY AND ACTION ON LIVER HISTOLOGY AND METABOLISM IN OVERWEIGHT PATIE... not-yet-due
Listed as ongoing, but also has a completion date 2010-018373-38 A Phase I trial of figitumumab, an IGF-1R antibody, in children aged 1-12 years old with relapsed/refractory Solid Tumours 2011-01-19 bad-data
Ongoing 2010-020924-22 United Kingdom National Randomised Trial for Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoma 2011 not-yet-due
Ongoing 2010-022119-20 A randomised controlled trial of extended warfarin treatment versus routine warfarin treatment for the prevention of recurrent venous thromboembolism and post thrombotic syndrome in patients being tre... not-yet-due
Ongoing, reported early 2010-022489-29 Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial not-yet-due
Ongoing 2010-022894-32 Dexamethasone Reduces Emesis After Major gastrointestinal Surgery (DREAMS trial) - A prospective, double-blind, multicentre, randomised control trial not-yet-due
Ongoing 2010-023189-27 The pharmacogenetics of vitamin D response in tuberculosis not-yet-due
Ongoing 2011-000366-35 Tackling Early Morbidity and Mortality in myeloma: assessing the benefit of antibiotic prophylaxis and its effect on healthcare associated infections not-yet-due
Ongoing 2011-000719-19 A Randomised Controlled Trial of the Efficacy and Mechanism of Levothyroxine Treatment on Pregnancy and Neonatal Outcomes in Women with Thyroid Antibodies. (TABLET: Thyroid AntiBodies and LEvoThyroxin... not-yet-due
Ongoing 2011-001211-31 A study of pazopanib efficacy and safety in patients with advanced clear-cell renal cell carcinoma and ECOG Performance Status 2 (PaZ02) not-yet-due
Ongoing 2011-001538-41 The impact of the combination of the GLP-1 analogue liraglutide (Victoza) and laparoscopic adjustable gastric banding (LAGB) on diabetes control not-yet-due
Ongoing 2011-001690-62 A randomised phase II clinical trial of conditioning cyclophosphamide and chemoembolisation with or without vaccination with dendritic cells pulsed with HepG2 lysate ex vivo in patients with Hepatocel... not-yet-due
Ongoing 2011-001955-35 Single Arm Phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) as non-toxic therapy against myeloid and lymphoid cancers not-yet-due
Ongoing 2011-002082-38 A study of the effects of Simvastatin on neutrophil function in elderly subjects not-yet-due
Ongoing 2011-003226-27 A Phase II Study of Pazopanib in Metastatic Merkel Cell Carcinoma not-yet-due
Not reported 2011-003595-36 Can muscle dysfunction in COPD be altered by oxygenation in patients with intermittent hypoxia on exertion? 2014-12-15 due-trials
Ongoing 2011-004199-12 An open label dose ranging study to optimise vitamin D levels prior to oesophagectomy not-yet-due
Ongoing, reported early 2011-004559-38 A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes. not-yet-due
Ongoing 2011-005023-40 ROMAZA: Phase I trial of combination therapy with romidepsin and azacitidine in patients with newly diagnosed, relapsed or refractory Acute Myeloid Leukaemia ineligible for conventional chemotherapy not-yet-due
Ongoing, reported early 2011-005134-19 An open label pragmatic randomised controlled trial of nicotine patch preloading for smoking cessation. not-yet-due
Ongoing 2011-005207-32 Phase II Randomised Trial of 5-Azacitidine versus 5-Azacitidine in combination with Vorinostat in patients with Relapsed Acute Myeloid Leukaemia ineligible for Intensive Chemotherapy not-yet-due
Ongoing 2011-005279-18 A RandoMised study of best Available therapy versus JAK Inhibition in patients with high risk Polycythaemia Vera or Essential Thrombocythaemia who are resistant or intolerant to HydroxyCarbamide. not-yet-due
Not reported 2011-006049-14 Vildalgliptin and Glucose Variability in Type 2 Diabetes 2014-05-19 due-trials
Ongoing 2012-000072-42 A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma – BEACON-Neuroblastoma Trial not-yet-due
Ongoing 2012-000214-11 BREVITY: A phase II study of brentuximab vedotin using a response adapted design in patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity not-yet-due
Not reported 2012-000332-25 vitamin D replacement to prevent lung injury following oesophagectomy - a randomised controlled trial. 2015-05-01 due-trials
Ongoing 2012-000510-10 A Phase IIa trial of 177 Lutetium Dotatate in Children with Primary Refractory or Relapsed High-Risk Neuroblastoma not-yet-due
Not reported 2012-000654-55 Spironolactone to Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (CKD): A Pilot Trial 2014-05-19 due-trials
Ongoing 2012-001970-28 Does CMV reactivation cause functional impairment of CMV specific CD4+ T-cells? The potential for valaciclovir to prevent CMV-mediated adverse modulation of the immune system in patients with ANCA-ass... not-yet-due
Ongoing 2012-002107-17 International Randomised Controlled Trial for the Treatment of Newly Diagnosed Ewing's Sarcoma Family of Tumours not-yet-due
Ongoing, reported early 2012-002795-13 A phase II trial of Cyclosporin A in Early Adverse Risk CLL not-yet-due
Ongoing 2012-003343-29 Simvastatin as adjuvant therapy to correct neutrophil dysfunction in older pneumonia patients - a randomised double blind placebo controlled trial not-yet-due
Ongoing 2012-003608-11 IciCLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL. not-yet-due
Ongoing 2012-003631-36 CALiBRe: Assessment of the Mechanism of Action of idelalisib (CAL-101) in B-cell Receptor Pathway Inhibition in CLL not-yet-due
Ongoing, reported early 2012-003835-40 A multicentre, phase II randomised controlled trial evaluating cabazitaxel versus docetaxel re-challenge for the treatment of metastatic Castrate Refractory Prostate Cancer, previously treated with do... not-yet-due
Reported results 2012-005257-22 Remifentanil intravenous patient controlled analgesia (PCA) versus intramuscular pethidine for pain relief in labour: a randomised controlled trial 2016-09-03 due-trials
Ongoing 2012-005538-12 A Randomised Trial of the FLAMSA-BU Conditioning Regimen in Patients with Acute Myeloid Leukaemia and Myelodysplasia Undergoing Allogeneic Stem Cell Transplantation not-yet-due
Ongoing 2012-005629-65 Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose finding study not-yet-due
Ongoing 2013-000341-39 A Phase Ib Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders not-yet-due
Reported results 2013-001332-22 PEPtalk 2: Pilot of a randomised controlled trial to compare VZIG and aciclovir as post-exposure prophylaxis against chickenpox in children with cancer 2015-06-30 due-trials
Ongoing 2013-001879-20 Phase I/II study to determine the maximum tolerated dose and activity of the combination of romidepsin and carfilzomib in relapsed or refractory peripheral T-cell lymphoma not-yet-due
Ongoing 2013-002636-25 A Randomised Multicentre Open Label Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 3 Chronic Kidney Disease not-yet-due
Ongoing 2013-003107-19 Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia not-yet-due
Not reported 2013-003387-32 Phase II Study Of The Impact Of AZD4017, A Selective 11b-HSD1 Inhibitor, On Biochemical Markers Of Bone Turnover In Post-Menopausal Osteopaenia 2014-12-10 due-trials
Not reported 2013-003643-31 Assessing the therapeutic efficacy and safety of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension (IIH). 2016-12-19 due-trials
Ongoing 2013-004246-41 A phase III randomised study of folic acid supplementation in the management of menopausal symptoms in cancer survivors and healthy postmenopausal women not-yet-due
Ongoing 2013-004307-39 Response to Optimal Selection of neo-adjuvant Chemotherapy in Operable breast cancer: A randomised phase III, stratified biomarker trial of neo-adjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide... not-yet-due
Ongoing 2014-000179-18 Local Oestrogen Treatment in Postmenopausal Women Undergoing Pelvic Organ Prolapse Surgery (LOTUS) - Feasibility Study not-yet-due
No trial status on register 2014-000227-24 A Study of Thiotepa, Ifosphamide, Etoposide and Rituximab for the treatment of relapsed or refractory primary central nervous system lymphoma bad-data
Ongoing 2014-000259-99 International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma not-yet-due
Ongoing 2014-002393-37 A single arm, two-stage, multi-centre, phase II clinical trial investigating the safety and activity of the use of BTT1023, a human monoclonal antibody targeting vascular adhesion protein (VAP-1), in ... not-yet-due
Ongoing 2014-003389-26 Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer not-yet-due
Ongoing 2014-003588-39 Torch: A phase II study to determine the safety and efficacy of the dual mTORC inhibitor AZD2014 and to investigate additional toxicities in combination with rituximab in relapsed refractory DLBCL not-yet-due
Ongoing 2014-003702-33 IMPRESS-AF: IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation not-yet-due
Other 2014-005066-30 International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemot... not-yet-due
Ongoing 2014-005659-19 A phase II study of the use of azacitidine for the treatment of patients with chronic graft-versus-host-disease who have failed therapy with corticosteroids not-yet-due
Ongoing 2015-002241-55 A phase II trial of pembrolizumab in patients with non-small cell lung cancer and a performance status of 2 not-yet-due
Ongoing 2015-005043-13 Evaluating different rate control therapies in permanent atrial fibrillation: A prospective, randomised, open-label, blinded endpoint study comparing digoxin and beta-blockers as initial rate control ... not-yet-due
Ongoing 2015-005454-35 Risk-stratified sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-novo post-transplant Lymphoproliferative disorder (PTLD) not-yet-due
Ongoing 2015-005497-38 Effects of TAMoxifen on the Mutant Allele Burden and Disease Course in Patients with MyeloprolifeRatIve Neoplasms not-yet-due
Ongoing 2016-000862-49 Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer? not-yet-due
Other 2016-002828-85 Paediatric Hepatic International Tumour Trial not-yet-due
Ongoing 2016-004879-46 AVAIL-T: A Phase 2a trial of Avelumab, an anti-PDL1 antibody, in relapsed and refractory peripheral T-cell lymphoma (PTCL) not-yet-due
Ongoing 2017-001215-37 A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome not-yet-due
Ongoing 2017-002762-44 A phase I/II study evaluating the safety and activity of Pegylated recombinant human Arginase (BCT-100) in Relapsed/refractory cancers of Children and young adults not-yet-due